Study to Monitor Susceptibility to Aztreonam of PA Infection From Patients With Cystic Fibrosis


Clinical Trial

Offered by: Nemours
Location: Orlando, FL

Trial Name

A Prospective Registry Study to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Patients With Cystic Fibrosis in the United States AIR-CF5

What is the trial about?

A study in adult and pediatric subjects with Cystic Fibrosis (CF) and pulmonary Pseudomonas aeruginosa (PA) infection.

Who can participate?

Patients ≥6 years of age with Cystic Fibrosis.

What is involved?

Participation in this study will last about 5 years after the first visit. Patients will be required to visit the clinic at least once per year for the next 5 years. This may coincide with a regular clinic visit. Sputum samples will be collected.

Contact Nemours Clinical Trials

Trial Name: A Prospective Registry Study to Monitor the Susceptibility to Aztreonam of Pseudomonas Aeruginosa Isolates From Patients With Cystic Fibrosis in the United States AIR-CF5

Contact Information

(800) 354-5690
clinicaltrials@nemours.org